Man Learns 13 Years of Chemotherapy May Have Been Unnecessary

Andrew Whitehead was 29 years old when doctors told him he had an aggressive spinal tumor and needed radical chemotherapy. He spent the next 13 years living in fear — taking monthly chemotherapy cycles, dealing with isolation, depression, persistent fatigue, chronic pain, infections, and immune suppression — believing a cancer in his neck could take his life at any moment.

Then he found out it might not have been necessary at all.

After the doctor overseeing his care, Professor Ian Brown, retired, Whitehead's tumor tissue was reexamined. An independent medical expert retained by his legal team concluded the tumor was Grade 1 — a low-grade classification that, his lawyer alleges, would not have required chemotherapy in the first place.

"It was devastating," Whitehead told the BBC. "I'd lived my life for so long in fear this cancerous tumor in my neck was going to at any point take my life away from me and then to find out I'd gone through all that for all those years... I couldn't believe it."

What the Lawyers Are Alleging

Whitehead's case is being handled by Brabners law firm, which is also representing around 40 other patients with similar claims against University Hospitals Coventry and Warwickshire NHS Trust.

His lawyer Fiona Tinsley says the treatment was originally planned for six cycles — roughly six months, which aligns with NHS guidelines for the chemotherapy drug temozolomide. Instead Whitehead continued receiving monthly cycles for years while repeated MRI scans showed no meaningful progression of the tumor.

"This is not a single clinical error," Tinsley said. "Rather, it appears to be a pattern of diagnostic failings in some cases, combined with a systemic failure to review and challenge treatment over many years."

Whitehead's tissue samples had originally been sent to Birmingham for analysis after surgery to remove his tumor in Coventry in 2010. He remembers what doctors told him at the time.

"I was told they needed to throw the kitchen sink at it," he said.

What the Hospital Says

University Hospitals Coventry and Warwickshire said it is "committed to providing the safest possible care" and confirmed that when the issue came to light at the end of 2023 it contacted all patients who were receiving temozolomide treatment to ensure they had appropriate support and care plans in place.

An independent review led by the Royal College of Physicians is currently underway and expected to be published in September. The hospital says it is fully supporting the process and cannot comment on individual cases due to ongoing legal proceedings.

The BBC said it repeatedly tried to reach Professor Brown for comment without success.

The Bigger Picture

Temozolomide is meant to be taken for a maximum of six cycles according to NHS guidelines — typically completed within six months. Multiple patients have told the BBC they received it significantly longer than that. The fact that Brabners is representing approximately 40 people with similar claims suggests this wasn't an isolated mistake in one patient's file.

Thirteen years of chemotherapy takes a toll that goes far beyond the physical. Whitehead described years of isolation and depression alongside the cumulative physical damage — his immune system suppressed, his body worn down by treatment that his own lawyer now argues he never needed.

The Royal College of Physicians review in September will be the next significant moment in determining how widespread the problem actually was and what accountability follows.

Curious for more stories that keep you informed and entertained? From the latest headlines to everyday insights, YourLifeBuzz has more to explore. Dive into what’s next.